Tocilizumab in Giant Cell Arteritis: Multicenter Open-Label Study of 22 Patients.

被引:0
|
作者
Santos-Gomez, Montserrat [1 ]
Loricera, Javier [1 ]
Blanco, Ricardo [1 ]
Hernandez, Jose L. [1 ]
Mera, Antonio [2 ]
Perez-Pampin, Eva [2 ]
Enriqueta Peiro, M. [1 ]
Castaneda-Sanz, Santos [3 ]
Humbria, Alicia [4 ]
Calvo-Alen, Jaime [5 ]
Aurrecoechea, Elena [5 ]
Narvaez, Javier [6 ]
Sanchez-Andrade, Amalia [7 ]
Vela, Paloma [8 ]
Diez Alvarez, Elvira [9 ]
Mata, Cristina [10 ]
Lluch Mesquida, Pablo [11 ]
Moll Tuduri, Concepcion [11 ]
Calvo-Rio, Vanesa [1 ]
Ortiz-Sanjuan, Francisco [1 ]
Pina Murcia, Trinitario [12 ]
Gonzalez-Vela, Carmen [1 ]
Riancho-Zarrabeitia, Leyre [1 ]
Gonzalez-Gay, Miguel A. [1 ]
机构
[1] Hosp Univ Marques de Valdecilla, IDIVAL, Santander, Spain
[2] Hosp Clin Univ Santiago de Compostela, Santiago De Compostela, Spain
[3] Hosp Univ La Princesa, Madrid, Spain
[4] Hosp Univ La Princesa, IIS Princesa, Madrid, Spain
[5] Hosp Sierrallana, Torrelavega, Spain
[6] Hosp Univ Bellvitge, Barcelona, Spain
[7] Hosp Univ Lucus Augusti, Lugo, Spain
[8] Hosp Gen Alicante, Alicante, Spain
[9] Hosp Leon, Leon, Spain
[10] Hosp Comarcal Laredo, Laredo, Spain
[11] Hosp Mateu Orfila, Mahon, Menorca, Spain
[12] IDIVAL, Epidemiol Genet & Atherosclerosis Res Grp Syst In, Div Rheumatol, Santander, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
814
引用
收藏
页码:S357 / S357
页数:1
相关论文
共 50 条
  • [31] Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study
    Koster, Matthew J.
    Crowson, Cynthia S.
    Giblon, Rachel E.
    Jaquith, Jane M.
    Duarte-Garcia, Ali
    Matteson, Eric L.
    Weyand, Cornelia M.
    Warrington, Kenneth J.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (06) : 861 - 867
  • [32] Tocilizumab in giant cell arteritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (02): : E100 - E100
  • [33] Tocilizumab in Giant Cell Arteritis
    Pflugfelder, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (01): : 87 - 88
  • [34] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [35] Tocilizumab in Giant Cell Arteritis
    Mariano, Vincent J.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2018, 26 (06) : 321 - 330
  • [36] Tocilizumab for giant cell arteritis
    Antonio, Aileen A.
    Santos, Ronel N.
    Abariga, Samuel A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (08):
  • [37] Denosumab in Giant Cell Rich Tumors of Bone: An Open-Label Multicenter Phase II Study
    Lipplaa, Astrid
    Schreuder, Willem H.
    Pichardo, Sarina E. C.
    Gelderblom, Hans
    ONCOLOGIST, 2023, : E1005 - E1104
  • [38] TOCILIZUMAB IN CRANIAL AND EXTRACRANIAL REFRACTORY GIANT CELL ARTERITIS: A MULTICENTER STUDY OF 312 CASES
    Sanchez-Bilbao, L.
    Loricera, J.
    Aldasoro, V.
    Melero, R.
    Castaneda, S.
    Maiz, O.
    Moriano, C.
    Villa-Blanco, I.
    Labrador-Sanchez, E.
    Hidalgo, C.
    Manrique Arija, S.
    Galindez-Agirregoikoa, E.
    Perez-Pampin, E.
    Garcia-Valle, A.
    Campos Fernandez, C.
    De Dios, J. R.
    Iniguez, C. L.
    Andreu Sanchez, L.
    Sanchez, J.
    Calderon-Goercke, M.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 34 - 35
  • [39] Tocilizumab for Giant Cell Arteritis in Japan over 2 Years: A Multicenter Retrospective Study
    Oda, Nobuhiro
    Fukui, Sho
    Yamaguchi, Toshihiro
    Nagase, Fumika
    Ito, Takanori
    Watanabe, Mitsuru
    Haji, Yoichiro
    Suyama, Yasuhiro
    Nomura, Atsushi
    Uechi, Eishi
    Suda, Masei
    Takizawa, Naoho
    Rokutanda, Ryo
    Tamaki, Hiromichi
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3328 - 3330
  • [40] Tocilizumab monotherapy after ultra-short glucocorticoid administration in giant cell arteritis: a single-arm open-label, proof-of-concept study
    Christ, Lisa
    Seitz, Luca
    Scholz, Godehard
    Sarbu, Adela-Cristina
    Amsler, Jennifer
    Buetikofer, Lukas
    Tappeiner, Christoph
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter M.
    LANCET RHEUMATOLOGY, 2021, 3 (09): : E619 - E626